Thursday, May 7, 2026

North Korea’s Financial Future: Will a Stock Market Emerge in 2026?

North Korea remains skeptical of stock markets, viewing them as capitalist tools, but shows growing interest in securities and AI-driven finance.

Winter Injuries: Identifying Joint Pain and When It Requires Professional Care

Cold weather can lead to joint pain; proper diagnosis and treatment are essential to avoid worsening conditions.

BYD Becomes First EV Giant to Break $100B Revenue Mark

BYD surpasses $100 billion in annual revenue, overtaking Tesla as the first EV company to achieve this milestone.

Health

CG Bio Group Launches Acellular Dermal Matrix-based Product Reallo Inject Fine

CG Bio launches Reallo Inject Fine, an acellular dermal matrix product, enhancing usability for medical professionals and expanding applications.

Ceragem Launches Global Standard for AI Home Healthcare, Accelerates Data Platform Push

Ceragem's new ISO/IEC report sets international standards for integrating home healthcare devices, focusing on user well-being and safety.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.
Latest

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

Why Celltrion’s STEQEYMA Auto-Injector is a Game Changer for Autoimmune Patients in North America

Celltrion expands its Steqeyma auto-injector lineup in Canada, enhancing market competitiveness and patient accessibility in North America.

Revolutionary CAR-T Treatment SynKIR-310 Outperforms CD19 CAR-T: What This Means for Blood Cancer Patients

Verismo Therapeutics' SynKIR-310 shows superior anti-tumor effects in preclinical studies, promising a safer CAR-T therapy for blood cancers.

New Breakthrough: HER2 Positive Stomach Cancer Treatment with Dual Targeted Therapy Shows 81% Tumor Size Reduction

A study reveals that combining trastuzumab deruxtecan and pertuzumab significantly reduces tumor size in HER2-positive gastric cancer.

LG Uplus Unveils Cutting-Edge IoT Solutions at WATER KOREA 2026: Revolutionizing Water Management

LG Uplus will showcase its IoT solutions for water management at the International Water Industry Expo, enhancing efficiency and safety.

AMD’s Latest MI355 GPU: How Upstage is Revolutionizing AI in South Korea

Upstage secures AMD GPUs for AI development, aiming for 10,000 units to enhance its language model and document processing solutions.

Revolutionizing Business: How SK AX’s AXgenticWire is Transforming Operations with Agentic AI

SK AX launches AXgenticWire, integrating agentic AI to enhance business operations and decision-making through collaborative AI systems.

How MedTech Spotlight 2026 is Connecting Korean Firms with Global Healthcare Leaders

Seoul will host MedTech Spotlight: New Impact Korea 2026 to foster global collaboration in the medical device industry on March 19-20.

How AMD’s New Alliance with Samsung is Set to Transform the AI Semiconductor Landscape in 2026

AMD and Samsung strengthen AI partnership, focusing on next-gen processors and memory for mobile and PC sectors.

HLB Pep Signs Deal with Japan’s ReproCELL to Supply Customized Neoantigen Peptides — The Future of Precision Medicine?

HLB PEP partners with Reprocell to supply customized neo-antigen peptides for personalized cancer treatment, targeting global markets.

Unlocking Treatment Potential: GI-102 and Pasritamig Clinical Trial Insights

GI Innovation has filed an IND application for a clinical trial on a combination therapy for metastatic prostate cancer in South Korea and the U.S.

How Hurom’s Innovative Commercial Juicers Are Revolutionizing the Cold Pressed Juice Market in 2026

Hurom showcased its commercial juicers at major events in New York and Hamburg, targeting the growing cold-pressed juice market.

How Zymfentra’s Prescription Rates Tripled in January: A Game-Changer for Celltrion

Celltrion's Zymfentra sees a 213% rise in U.S. prescriptions, marking significant growth since its launch, driven by market demand.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.